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Cl-out is a novel cooperative optogenetic tool for
extruding chloride from neurons
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Chloride regulation affects brain function in many ways, for instance, by dictating the
GABAergic reversal potential, and thereby influencing neuronal excitability and spike timing.
Consistent with this, there is increasing evidence implicating chloride in a range of
neurological conditions. Investigations about these conditions, though, are made difficult by
the limited range of tools available to manipulate chloride levels. In particular, there has been
no way to actively remove chloride from neurons; we now describe an optogenetic strategy,
‘Cl-out’, to do exactly this. Cl-out achieves its effect by the cooperative action of two different
component opsins: the proton pump, Archaerhodopsin and a chloride channel opsin.
The removal of chloride happens when both are activated together, using Archaerhodopsin
as an optical voltage clamp to provide the driving force for chloride removal through the
concurrently opened, chloride channels. We further show that this novel optogenetic strategy
can reverse an in vitro epileptogenic phenotype.
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N
ormal brain function arises from a delicate, and
continually fluctuating, interplay between excitatory and
inhibitory synaptic forces, and is therefore very sensitive
to anything that affects the balance between excitation and
inhibition. Chloride regulation in neurons is particularly
important in this respect, because the major forms of synaptic
inhibition, including GABAA, GABAC and glycine receptors, are
chloride-conducting channels1–3. Consequently, changes in
intraneuronal chloride levels can markedly alter the synaptic effects
of both GABA and glycine. Chloride balance further influences
neuronal function by modulating transmitter loading into vesicles4,5,
by affecting neuronal acid–base balance through interactions with
bicarbonate6,7, and cell volume through osmotic effects8.
The level of intraneuronal chloride fluctuates widely both over
time9–11 and in different parts of the neuron12,13, suggesting that
this may play a key role in dictating the functional state of the
neuron. Very low levels of intraneuronal chloride means that
the GABAergic events are strongly hyperpolarizing, and the
inhibitory effect is very strong. Raised intraneuronal chloride,
on the other hand, arising either by excess chloride entry or
reduced clearance, shifts the GABAergic reversal potential
(EGABA) in a positive direction, and GABA can even become
excitatory if EGABA exceeds action potential threshold. Such
chloride-dependent disinhibition is thought to be a major factor
in several brain disorders14–17, most notably epilepsy18–21.
The relative expression levels of two different cation-chloride
co-transporters, KCC2 and NKCC1 (ref. 22), as well as local
impermeant anions are reported to influence the baseline chloride
balance23. At other times, intense synaptic bombardment,
especially when there is concurrent glutamatergic and
GABAergic activation24, can overwhelm the capacity of neurons
to regulate chloride levels, and intraneuronal chloride rises
sharply at these times25,26.
The true extent of these physiological and pathological
dynamic changes, however, is not known, partly because we lack
the tools for manipulating chloride. Optogenetics has introduced
many new tools for regulating neuronal function27, including the
ability to load chloride into neurons using the optogenetic
chloride pump, Halorhodopsin28. We used this strategy to
demonstrate how raised intraneuronal chloride leads to an
acute increase in network excitability29 and alterations in spike-
timing, consistent with patterns of activity that have been
recorded in epileptic animals30,31. Similarly, the specific
KCC2 antagonist, VU0463271, also rapidly induces epileptiform
discharges in brain slice preparations32. The influence of chloride
balance on spike-timing, mediated through its effect on GABAA
inhibition29, also has implications for a wide range of neuronal
activity, including spike-time dependent plasticity, neuronal
clustering and information transfer through networks with
weak glutamatergic synaptic connections.
Reducing intraneuronal chloride, on the other hand, has
proved difficult. As such, we only really have the means to
manipulate intracellular chloride in an upwards direction. If we
were able to reduce intracellular chloride, this would not only
facilitate investigations into chloride regulation and its conse-
quences, it may also provide a means of treating the various
neurological conditions associated with raised chloride. The
diuretic, bumetanide has some efficacy in this regard, by blocking
NKCC1, and has shown promising antiepileptic action in animal
models33. Its effect, however, is likely to be weak, acting only
on chloride entry and not promoting chloride extrusion at all.
A recent clinical trial to repurpose bumetanide for treatment of
childhood epilepsies was terminated early because of otolaryngeal
side-effects34. Significantly though, there are no means currently
to remove chloride from neurons. We therefore decided to
create one using optogenetics (Fig. 1), by coupling the
hyperpolarizing proton pump, Archaerhodopsin (Arch)35,
with one of the newly described optogenetic chloride
channels36,37. We demonstrate the action of this new
optogenetic strategy using dissociated neuronal cultures, and
then provide a proof of principle of its network effect, using it to
reverse a simple, in vitro model of epilepsy.
Results
Optogenetic manipulation of intraneuronal chloride levels.
We first considered trying to reverse the orientation of
Halorhodopsin so that it pumps chloride out of cells, but this
strategy is problematic because the period of chloride extrusion
would be accompanied by intense depolarization of the neurons.
A second strategy presented itself with the publication of two
different optogenetic chloride channels, ChloC36 and the anion
channel rhodopsins (ACRs)37. We reasoned that if we could
control the membrane potential, then we would also have control
over the direction of chloride movement through these
channnels. We demonstrated this proof of principle by
performing gramicidin perforated patch clamp recordings of
dissociated cultured neurons, expressing either ChloC or GtACR.
This allows a non-invasive measurement of GABAergic reversal
potentials induced by brief puffs of the GABAA agonist muscimol
delivered from a nearby micropipette. We measured EGABA before
and after activation of the optogenetic chloride channels, while
holding the cell at a relatively depolarized, or a hyperpolarized
level. A voltage ramp was delivered close to the timing of the peak
GABAergic conductance. In both cases, EGABA shifted towards
the holding membrane potential: when the cells were held at
 50mV, there was a positive shift in EGABA for both ChloC
(avg±s.e.m.: 2.69±0.55mV, n¼ 6) and GtACR (7.93±1.38mV,
n¼ 5); when instead the cells were held at  80mV, there
was a negative shift in EGABA (ChloC:  1.93±0.61mV, n¼ 5;
GtACR2:  3.43±0.64mV, n¼ 5).
We then investigated whether the optogenetic proton pump,
Arch, could provide the hyperpolarizing voltage clamp to drive
chloride extrusion through a concurrently activated chloride
channel. Since the effect depends critically on the Arch opsin
altering the cell’s membrane potential, these assessments
could not be done using voltage clamp. Instead, we recorded
cells in current clamp, again using gramicidin patch pipettes,
and measured the shift in the inhibitory synaptic potential
(‘GABADV’), induced by a brief puff of muscimol, as a proxy
for a direct, voltage-clamp measure of EGABA (Fig. 1c).
Co-transfection strategies, using separate vectors for the two
opsins, produced a mixed population with many neurons only
expressing one of the opsins, and only some expressing both.
Recordings of these doubly-transfected neurons suggested that
this strategy could be successful. Critically, however, we showed
that cells expressing ChloC or GtACR in isolation tended to
produce a small positive shift in GABADV (Fig. 1d), so any
transfection strategy resulting in networks where significant
numbers of singly-transfected neurons expressing these channels
are likely to produce deleterious effects, rather than improve-
ments in network behaviour. We therefore incorporated the
expression of both opsin elements into a single-expression
system. We used two different co-expression methodologies
linking two different pairs of opsins, to yield four different
constructs in total (Fig. 2). The first co-expression method used a
‘self-cleaving’ T2A linker peptide, derived from Thosea signa
virus, which allows two separated proteins to be expressed
under a single promoter38. The second method used a b-HK
linker sequence39, to create a single-fusion protein by
concatenating the two opsins. Because the function of these
paired expression systems depend on the cooperative action of
both opsin components, we term these new proteins ‘co-opsins’,
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and this specific co-opsin, we have called ‘Cl-out’, named for its
cellular effect of removing chloride from the cytosol.
Co-opsin expression and function. The constructs produced
good membrane localization (Supplementary figure 2), without
affecting either baseline input resistance (Cl-out4 constructs;
non-transfected cells, n¼ 5, RN¼ 1.30±0.06MO; transfected
cells, n¼ 5, RN¼ 1.74±0.26MO; p¼ 0.176, NS.), or EGABA
(non-transfected cells, n¼ 5, EGABA¼  51.8±2.8mV; trans-
fected cells, n¼ 5, EGABA¼  47.2±2.8mV; P¼ 0.249, NS).
Importantly, the distinct functions of both individual optogenetic
elements were readily seen in whole-cell patch clamp recordings
using a high chloride electrode filling solution (Fig. 2b).
Blue (488 nm) illumination activates preferentially the chloride
channel, producing a strong depolarization in cells filled with
chloride, whereas green illumination (561 nm) preferentially
activates Arch leading to a hyperpolarization. When both
opsins were simultaneously activated, in cells recorded through
gramicidin perforated patch clamp, it induced a rapid shift
in shape of the muscimol-triggered post-synaptic potential
(Fig. 2c-i). Notably some recordings even showed a reversal of the
sign of the post-synaptic potential (see Fig. 4a, lower trace),
demonstrating that the change is unlikely to be explained by a
change in conductance, but rather by a change in EGABA. This was
further confirmed by voltage-clamp ramp recordings, showing
no change in the slope (Supplementary figure 3; percentage
conductance change¼  3.5±2.5%, n¼ 3). We concluded
therefore that Cl-out activation produces its effect on GABAergic
events by reducing intracellular chloride levels. In contrast,
activation of the individual opsins singly had little or no effect on
subsequent GABAergic events (Fig. 1c, Fig. 2c-ii).
We assessed the chloride removal by measuring the
GABADV induced by opsin activation (5 s illumination) with
the two different Cl-out constructs incorporating either ChloC
(Cl-out1 and 3) or GtACR (Cl-out2 and 4; Fig. 3). We failed to
get good expression of Cl-out3, but all other co-opsins induced
significant negative GABADV, and if cells were preloaded
with chloride by blocking KCC2 using VU0463271
(10mM; baseline GABApeak¼  74.7±3.3mV, n¼ 9; VU0463271
GABApeak¼  55.9±3.0mV, n¼ 6; Po0.005), the negative shift
was significantly increased over what was possible from baseline
(baseline GABADV¼  1.89±0.33mV; GABADV with
VU0463271¼  4.19±0.58mV, Po0.005 t-test; Fig. 3), indicat-
ing that concentration gradient and leakage does impose an upper
limit on the degree of chloride extrusion.
Following the end of the illumination, the neurons slowly
accumulated chloride once more, but with a substantially longer
time constant (VU0463271 bathed neurons, t¼ 37.5±6.7 s;
n¼ 7; Fig. 4) than of previous measures of the correction of
optogenetically altered chloride levels (t¼ 8–12 s)28,29. In cells
bathed additionally in bumetanide (10 mM to block NKCC1),
the recovery was significantly slower (t¼ 58.2±11.5 s; n¼ 7;
Po0.025; Fig. 4b,c), an effect that was reversed by washing
out bumetanide (t¼ 33.1±5.1 s; n¼ 5). These results suggest
both NKCC1 and KCC2 contribute significantly to chloride
movements across the cell membrane at rest.
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Figure 1 | EGABA can be modulated, by using voltage clamp to direct chloride movement through ChloC or GtACR. (a) Example traces of gramicidin
patched neurons which express GtACR, showing control responses to a puff of the GABAA agonist, muscimol (black) when the cell is held at either
 50mV (upper) or 80mV (lower). The blue traces are repeat trials in the same cells, with a prior activation of GtACR for 4 s, stopping 200ms before
the muscimol application. Voltage ramps were applied close to the peak of the muscimol response to determine EGABA more accurately (the ramps are
excised from this figure so as to illustrate better the change in the IPSC shape. An example showing the ramps is in Supplementary figure 1). (b) Pooled
data showing that the holding potential influences opsin-mediated shift in EGABA, with positive shifts resulting when the cell is held at  50mV, and
negative when the cell is hyperpolarized (ChloC, n¼ 6 neurons; GrACR2, n¼ 5). (c) Example recording of a neuron transfected with GtACR2 only,
illustrating the current clamp assay of the shift in EGABA. (d) Group data for the shift in IPSP voltage following a 5 s opsin activation, in cells transfected
either with GtACR2 (n¼ 6) or ChloC (n¼ 8).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13495 ARTICLE
NATURE COMMUNICATIONS | 7:13495 | DOI: 10.1038/ncomms13495 | www.nature.com/naturecommunications 3
Cl-out can persistently reduce network excitability. We next
examined whether we could use this approach to modulate the
activity patterns in large networks of neurons simultaneously
(Fig. 5). We incorporated the Cl-out1 and Cl-out4 constructs
under the pan-neuronal, hSyn promoter, together with an
enhanced yellow fluorescent protein (EYFP) marker sequence,
into adeno-associated viral vectors, and injected the virus into the
left cerebral ventricle of newborn mouse pups. Both vectors
achieved in vivo expression, but levels of Cl-out1 were far better
than for Cl-out4, so subsequent network modulation experiments
were performed only for Cl-out1 constructs. Animals were
allowed to grow to maturity, and at between postnatal 2–4
months age, they were killed to prepare coronal brain slices. We
selected brain slices showing evidence of significant EYFP label-
ling in the hippocampal formation, and recorded extracellular
activity using Neuronexus probes in the CA1 pyramidal layer. We
recorded baseline periods, before introducing the KCC2 blocker,
VU0463271 (10 mM) into the bathing media. As reported pre-
viously32, VU0463271 perfusion induced a marked increase in the
network excitability, with the appearance of large spontaneous
network discharges and also a much larger response to electrical
stimulation (Fig. 5b). We then delivered a series of 25 s
illuminations, at 30 s intervals (83% duty cycle), using both blue
(488 nm) and green light (561 nm) to activate the expressed Cl-
out1 co-opsin. We tested network excitability in each cycle of
illumination, during the 5 s dark period, following the same
protocol described previously29. In all cases, this rapidly reversed
the hyperexcitable state back to baseline levels, as measured both
by the near abolition of spontaneous events (Fig. 5c; normalized
frequency following light activation¼ 15.3±2.8%; highly
significant difference from 100%, Poo0.001) and the intensity
of the responses to electrical stimulation (Fig. 5d; Normalized
power, VU, 38.4±12.4; VUþ light, 6.1±2.1; Po0.05), even in
the continued presence of perfusing VU0463271.
We next asked whether these effects could be achieved by
activating the individual component opsins (Fig. 6). For the
ArchT experiments, we used animals transfected only with that
construct (Fig. 6a). For the ChloC experiments, we used Cl-out1
transfections, utilizing the separation of spectral sensitivities of
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the two opsins (see Fig. 2b), and contrasted the effects of
illuminating only with blue light with combined blue/green
illumination (Fig. 6b). For both opsins individually, the intensity
of the response to electrical stimulation following illumination
tended to increase, and substantially so in two of the ArchT
experiments (Fig. 6c). These experiments confirmed that the
restorative action of Cl-out1 in reducing network excitability was
indeed due to the cooperative action of the two component
opsins.
Once the illumination was terminated, the hyperexcitable state
was re-established, but only slowly, over many tens of seconds
(example traces in Figs 5b and 6b; pooled data in Supplementary
figure 4), consistent with the cellular time constants shown in
Fig. 4. This shows that the inhibitory benefit of Cl-out far outlasts
its activation, consistent with our cellular measures (Fig. 4). This
property represents a significant advance in our optogenetic,
antiepileptic armoury because it is directed at reinvigorating the
brain’s own endogenous protective mechanism, which previous
work has shown to be extremely powerful40,41, an effect that long
outlasts the period of optogenetic activation.
Finally, we examined whether manipulating intraneuronal
chloride levels in this way could influence spike timing, because
there is extensive evidence that spike time is strongly regulated by
GABAA activation42,43. We tested, using multiunit recordings,
whether Cl-out activation changed the entrainment of spiking to
the dominant field oscillation, in the opposite direction to the
effect shown previously, when we drove chloride into
neurons using Halorhodopsin29. We first applied VU0463271,
to load chloride generally into neurons, and then assessed
spike entrainment before and after Cl-out activation. These
experiments showed a marked sharpening of the entrainment of
spikes, as indicated by a significant reduction in the half-width
index, which is a measure of the skew of the histogram towards a
single peak in the oscillation. This reduction only occurred with
co-activation of both opsins together, and not with activation of
either ArchT or ChloC alone (Supplementary figure 5).
Discussion
We have developed a novel approach to using optogenetics, in
which two opsins are used cooperatively to achieve the desired
alteration of neuronal function. Whilst others have expressed
different optogenetic proteins in single cells before39, these
previous studies have done so to provide different optogenetic
effects brought about by different colour light; their aim was
always to activate one or other protein, and not both together,
within the constraints offered by their spectral sensitivities. In
contrast, the effect we sought was dependent on the cooperative
action of both optogenetic elements. This is the first utilization of
optogenetics to provide a voltage-clamp effect to move ions
unidirectionally through a channel, and in this way, provides the
first means to actively extrude chloride from neurons.
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The dependence of the Cl-out effect on Arch pumping a
proton out of the cell may conceivably alter the pH balance
slightly, increasing the intracellular pH relative to outside. This,
though, is likely to be minimized by the presence of intracellular
carbonic anhydrase and the extracellular pH buffers. It is
important to note, however, that such a pH shift would make
the bicarbonate reversal potential marginally more positive
(that is, the opposite of the EGABA shift we actually measured),
meaning that the change we measure cannot be ascribed to any
pH change, a point that is further proved by our control
experiments using Arch activation alone.
Our development complements our recent demonstration
that chloride can be driven into neurons acutely using
Halorhodopsin28,29, so that now we have the facility for
bidirectional control over chloride levels. Currently, this could
not be achieved in the same cells, because the spectral activation
curves of Halorhodopsin and the Arch component of the Cl-out
constructs overlap. So the potential is only realized for one
strategy in a given cell, but the co-opsin strategy that we describe
here will lend itself to other combinations of opsins with shifted
spectral sensitivities as they become available. In this regard, it
should also be noted that combining GtACR1 with ArchT might
yield a co-opsin which could be activated by a single wavelength,
but the rather slow kinetics of GtACR1 would then present other
problems regarding the temporal matching of the co-opsin effect.
Research using these new tools for manipulating chloride will also
benefit from developments in imaging chloride levels in cells44–46,
and has the potential to usher in a new era of research into the
role of chloride in neurons. As we have mentioned, chloride levels
are highly variable in different cells and across different times,
and given what we know about the consequences for neuronal
function, it seems highly likely that chloride regulation is an
important mechanism for dictating neuronal, network and brain
states. In particular, by altering the strength of GABAergic
control, changes in intraneuronal chloride is hypothesized to
influence spike timing and jitter, and this theory can now be
tested. Our new tool also has the potential to correct chloride
loading in neurons, a common feature of epileptic networks.
Accordingly, we have provided a demonstration that Cl-out can
reverse an epileptic phenotype in vitro, and also alter spike-
timing, paving the way for future explorations of its effect on
various spike-time dependent mechanisms, and also on
pathological processes, in more realistic animal models and
potentially ultimately in man.
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Figure 7 | Altered spike-timing following Cl-out1 activation. (a) Rose plot derived from one example recording, indicating the times of action
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Methods
Animal Regulation. All animal handling and experimentation were done
according to UK Home Office guidelines, according to the requirements of the
United Kingdom Animals (Scientific Procedures) Act 1986.
rAAV cloning and production. The different vectors were based on
pAAV-hSyn-ChloC-2A-tDimer (purchased from Addgene #52495). To construct
pAAV-hSyn-ChloC-2a-ArchT-GFP (Cl-out 1), ArchT-GFP was isolated
from pAAV-CAG-ArchT-GFP (purchased from Addgene #29777) and subcloned
into pAAV-hSyn-ChloC-2A-tDimer after removal of tDimer component using the
BamHI and HindIII restriction sites. For the linked protein (pAAV-hSyn-ChloC-
EYFP-bHK-Arch), EYFP-bHK-Arch cDNA was custom synthesized by GeneArt
Company and subcloned into the vector using KpnI and HindIII restriction sites,
excluding the 2A component. GtACR2 cDNA was then synthesized by GeneArt.
It was subcloned into the pAAV-hSyn-ChloC-2a-ArchT-GFP and pAAV-hSyn-
ChloC-EYFP-bHK-Arch vectors to replace ChloC, using EcoRI and KpnI restric-
tion sites. Sequence confirmation was outsourced (GATC Biotech). All vectors were
amplified using recombinant deficient strain of E.Coli (OneShot Stbl3, Invitrogen)
and purified using EndoFree Maxi Kit (QIAGEN #12362). Viral vectors were
packaged as AAV serotype 2 by University of North Carolina vector core.
Dissociated neuronal culture. Assessment of the chloride-extrusion effect of the
different proteins was performed using dissociated neuronal cultures. Primary
neuronal cultures were prepared from rat pups at embryonic day 18–20 in the
following way. A pregnant Sprague–Dawley rat was killed by cervical dislocation
and a sagittal incision was made in the abdominal area to remove the pups. The
neocortex and hippocampal tissue was isolated from the pups, and digested using
papain enzyme (Sigma Aldrich) for 40min. Cells were then dissociated within the
growing medium (Neurobasal A, 2% B-27 supplement, 1% of fetal bovine serum,
0.5% glutamate, and 0.5% antibiotic–antimicotic, GIBCO Invitrogen) by gentle
agitation using a pipette gun with a 10ml tip. Transfection was done by
electroporation using Rat Neuron Nucleofactor kit (Lonza Amaxa). For each
electroporation, B5 million cells were collected by centrifugation (80 relative
centrifugal force) for 5min. Cell pellets were re-suspended in 100 ml nucleofactor
solution and mixed with 1 mg of plasmid DNA. Cells were electroporated using an
electroporation machine (Amaxa; programme G-013). Cells were then plated on
pre-coated coverslips using poly-L-lysine with 1:10 dilution. Medium was changed
3 and 24 h post-plating. All experiments were performed after DIV 10.
Patch clamp experiments. Recordings were made using one of two laser
spinning disc confocal microscopes (Visitech; Olympus) fitted with Patchstar
micromanipulators (Scientifica) mounted on a Scientifica movable top plate.
Electrophysiological data were collected using a Multiclamp 700B amplifier
(Molecular Devices) and Digidata acquisition boards connected to Dell desktop
computers running pClamp software (Molecular Devices). During the entire
recording, cells were bathed in circulating oxygenated (95% O2/5% CO2) artificial
cerebrospinal fluid (ACSF) solution (in mM: 125 NaCl, 26 NaHCO3, 10 glucose,
3.5 KCl, 1.26 NaH2PO4, 1.2 CaCl2 and 1 MgCl2; perfusion at 1–3mlmin 1)
heated to 33–37 C by a sleeve heater element (Warner Instruments) around the
inflow tube.
Whole-cell patch. Whole-cell recordings were made using 3–7MO pipettes made
of borosilicate glass (Harvard apparatus). Electrode filling solution used was either
low Cl (K-methyl-SO4 125mM, Hepes 10mM, Mg-ATP 2.5mM, NaCl 6mM;
290mOsM and pH 7.35) or high Cl (KCl 135mM, Na2ATP 4mM, Na3GTP
0.3mM, MgCl2 2mM, and Hepes 10mM; 290mOsM and pH 7.35).
Perforated gramicidin patch. Gramicidin perforated patch recordings were made
using 3–7MO pipettes (borosilicate glass; Harvard Apparatus) filled with a high
Cl electrode filling solution. Fresh Gramicidin (Sigma Aldrich, G5002) stock was
made daily with 5mgml 1 concentration in dimethylsulfoxide. Gramicidin stock
was added to the high Cl electrode filling solution to achieve a final concentration
of 0.1mgml 1 and mixed by 40 s vortexing and 5 s sonication. Gramicidin
electrode filling solution was then filtered using a 0.45 millex pore filter and used
for patching straight away. Experiments were performed when series resistance had
stabilized below 100MO, which was typically achieved B30mins after patching.
The series resistance was required to be stable (o10% fluctuation) during the time
course of data collection.
For voltage-clamp measurements of EGABA (Fig. 1a), recordings were made in
voltage-clamp mode, with repeated 200ms duration test ramps (triangular
up–down function; peak  50mV; trough  90mV; slope±400mV s 1) applied
at baseline and also at close to the peak of GABAergic current (IGABA). All other
assays of EGABA were made in current clamp mode, because we were assessing
functionality of different Cl-out constructs in which the effect is critically
dependent on a voltage shift provided by Arch. For this reason, voltage clamping
the cells would have abolished the effect. We therefore measured the average shift
in GABAergic inhibitory post-synaptic potentials (IPSPs) induced by muscimol
(100 mM) application delivered close to the recorded neuron, from a patch pipette
coupled to a picospritzer (Parker Instrumentation, 10ms pressure pulses,10–20
PSI)(see Fig. 1c). IPSPs were measured in the presence of 2mM kynurenic acid, to
block all glutamatergic synaptic events. The timing of the puff was coordinated
with the illumination (optogenetic activation) via the pClamp software coupled to a
Digitimer box. The shift in IPSP was calculated from averages of the membrane
potential over 200ms epochs, centred on the peak of the muscimol induced
conductance, for pairs of events before and after activation of the Cl-out constructs.
This measure reflects the shift in EGABA, but is not a direct measure, and so we refer
to it as GABADV, to make this distinction clear. If action potentials occurred,
these were curtailed at the peak of GABA event, before the measurement.
Optogenetic expression. For general neuronal expression of the optogenetic
proteins, viral vectors (pAAV-hSyn-ChloC-2a-AchT-GFP manufactured by
UNC viral vector core using plasmid constructs provided by ourselves; rAAV5/
CAG-ArchT-TdTomato (UNC)) were injected into wild-type mice (C57BL/6 J).
Injections were made into postnatal 0-day-old pups. The pups had local anaesthetic
(EMLA, AstraZeneca) cream applied to the left top of their head, and were anes-
thetized subsequently using isofluorane inhalation. A single injection of virus was
made using a 10mL Hamilton syringe, with a bevelled 36 gauge needle (World
Precision Instruments)B1mm anterior to lambda, and 1mm lateral to the midline
into the left hemisphere at 1.7–0.8mm deep to the skin (four separate 200 nl
injections, deepest first). Approximately 0.8ml (B1011–1012 viral particles) was
injected over a 12min period. Animals were allowed to recover. Subsequent elec-
trophysiological recordings were made between the ages of 5 weeks to 3 months.
Brain slice experiments. Coronal brain slices (350 mm for patch clamp
experiments or 400 mm for network activity experiments) were prepared from the
injected animals, at age 2–4 months (male), on ice-cold oxygenated (95% O2/5%
CO2) artificial cerebrospinal fluid (ACSF: 125mM NaCl, 26mM NaHCO3, 10mM
glucose, 3.5mM KCl, 1.26mM NaH2PO4, 3mM MgCl2). After cutting, the slices
were transferred to incubation, submerged or interface chamber (room tempera-
ture) perfused with oxygenated ACSF (ACSF: 125mM NaCl, 26mM NaHCO3,
10mM glucose, 3.5mM KCl, 1.26mM NaH2PO4, 2mM CaCl2, 1mM MgCl2) for
at least 1 hour before transfer to a recording interface chamber (33–36C), after
which time they perfused with slightly lower Ca2þ ACSF (1.2mM CaCl2; ACSF
otherwise as before). The divalent cation concentration followed the protocol of
Sanchez-Vivez and McCormick (1999). In some experiments, cation-chloride
cotransporters were blocked using 10 mM of VU0463271 (Tocris) to block KCC2,
and 10 mM bumetanide (Tocris) to block NaKCC1 (minimum drug incubation
time of 20min).
Extracellular recordings were made using tetrodes in a diagonal arrangement
separated by 50–100 mm (Neuronexus), connected to a 1401–5 Analog-Digital
converter (Cambridge Electronic Design, Cambridge) and using Spike2 software
(Cambridge Electronic Design) running on a desktop computer (Dell).
Multichannel extracellular recordings were digitized at 20 kHz for high frequency
bandpass (300–1,000Hz) and 5 kHz for low-frequency bandpass (1–300Hz), using
16 linear 4-channel-probes in diamond configuration (Q1x1-tet ‘tetrode’;
NeuroNexus) connected to a ME16-FAI-mPA-system and MC_Rack software
(Multichannel Systems, Reutlingen). The tetrodes were mounted on patchmaster
micromanipulators, and recordings were made from the pyramidal cell layer in
CA1. Bipolar electrical stimulation (0.1ms duration) was delivered via tungsten
electrodes onto the white matter. Optogenetic proteins were activated by 561 nm,
50mW solid-state laser (Cobolt) connected to a fibre optic with a fine cannula
(400 mm core, 0.20 NA; Thorlabs; after optimizing the optic fibre coupling, the
unfiltered light at the cannula tip was measured at 15–30mW) synchronous with
blue epi-fluorescence illumination (460±20 nm excitation filter) controlled using
an electrically-coupled, mechanical shutter (Sutter Instruments), and delivered
through a 4 air objective (0.28 NA, Nikon). The central illumination of the
epifluorescent blue illumination was B10mWmm 2.
Code availabilty. Analyses were done using in-house software (available on
request) implemented on either Igor (Wavemetrics) or Matlab. Sample sizes
were chosen based on the large effect sizes found in our previous studies using
Halorhodopsin to increase intracellular Cl (ref. 29). Recordings and analyses
were not blinded.
Data availability. The data that support the findings of this study are available
from the corresponding author on reasonable request.
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